Edition:
United Kingdom

People: Axsome Therapeutics Inc (AXSM.OQ)

AXSM.OQ on NASDAQ Stock Exchange Global Market

24.85USD
19 Jul 2019
Change (% chg)

$-0.45 (-1.78%)
Prev Close
$25.30
Open
$25.20
Day's High
$25.25
Day's Low
$24.44
Volume
253,995
Avg. Vol
345,369
52-wk High
$27.99
52-wk Low
$1.94

O'Gorman, Cedric 

Dr. Cedric O'Gorman, M.D., M.B.A. is a Senior Vice President- Clinical Development and Medical Affairs of the Company. Dr. O'Gorman has served as our Senior Vice President, Clinical Development and Medical Affairs since September 2017. Prior to joining us, Dr. O'Gorman was the Vice President of Medical Affairs at Intra-Cellular Therapies since December 2014. Before that, Dr. O'Gorman was the U.S. medical lead for psychiatry at Genentech/Roche. Prior to Genentech/Roche, Dr. O'Gorman spent 5 years at Pfizer representing medical affairs on several branded neuroscience products including Geodon for schizophrenia and bipolar disorder, and Pristiq for major depressive disorder. Dr. O'Gorman received his medical degree from the National University of Ireland, in Galway, Ireland, trained at the Institute of Psychiatry, in London, England, and earned his Master of Business Administration from the New York University Stern School of Business.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --